Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patent Reform Act of 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
National Neurological Diseases Surveillance System Act of 2010
Client: PARKINSON'S ACTION NETWORK · Firm:
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2009 · second_quarter · Q2
HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).
Source: Senate LDA
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
National Neurological Diseases Surveillance System Act of 2010
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).
To reauthorize surface transportation research, development, and technology transfer activities, and for other purposes.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).
Stem Cell Research Enhancement Act of 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
National MS and Parkinson's Disease Registries Act
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).
Stem Cell Research Enhancement Act of 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
Patent Reform Act of 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362/S 1273, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1428, "To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide wartime disability compensation for certain veterans with Parkinson's disease," all sections; HR 2569, "Enhancing Small Business Research and Innovation Act of 2009," section 102 regarding participation of venture capital funded small businesses and all sections relating to the National Institutes of Health; S 914, "Cures Acceleration Network and National Institutes of Health Reauthorization Act of 2009," all sections; "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010," all sections related to the National Institutes of Health; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to FDA; Overcoming Barriers to Biomedical Research and Therapy Development at the National Institutes of Health (not related to any pending legislation).
Physician Pathology Services Continuity Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 5/HR. 3, " Stem Cell Research Enhancement Act" all sections; H.R.5874, "National MS Disease Registry Act" all sections; S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2008," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" all sections related to FDA; "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
National MS Disease Registry Act
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 5/HR. 3, " Stem Cell Research Enhancement Act" all sections; H.R.5874, "National MS Disease Registry Act" all sections; S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA.
Medicare Improvements for Patients and Providers Act of 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 2931, the "Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2008," all sections. H.R. 6331 the "Medicare Improvement for Patients and Providers Act," all sections.
Medicare Improvements for Patients and Providers Act of 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.
Wired for Health Care Quality Act
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.
Medicare Access to Complex Rehabilitative and Assistive Technology Act of 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 2931, the "Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2008," all sections. H.R. 6331 the "Medicare Improvement for Patients and Providers Act," all sections.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 5/HR. 3, " Stem Cell Research Enhancement Act" all sections; H.R.5874, "National MS Disease Registry Act" all sections; S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2009
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 5/HR. 3, " Stem Cell Research Enhancement Act" all sections; H.R.5874, "National MS Disease Registry Act" all sections; S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2008," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" all sections related to FDA; "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S. 5/HR. 3, " Stem Cell Research Enhancement Act" all sections; H.R.5874, "National MS Disease Registry Act" all sections; S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA.
Small Business Expensing Permanency Act of 2003
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.
To suspend temporarily the duty on Procion Yellow H-EXL.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 493, "Genetic Information Nondiscrimination Act," all sections. H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. H.R. 2642 the "Consolodated Supplemental Appropriations Act, 2008," all sections related to National Institutes of Health and the Food and Drug Administration. "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA;
To repeal the sunset on the increased assistance pursuant to the dependent care tax credit provisions of the Economic Growth and Tax Relief Reconciliation Act of 2001 and to make the credit refundable.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
H.R. 493, "Genetic Information Nondiscrimination Act," all sections. H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. H.R. 2642 the "Consolodated Supplemental Appropriations Act, 2008," all sections related to National Institutes of Health and the Food and Drug Administration. "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA;
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Enhancing Drug Safety and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Food and Drug Administration Amendments Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Biologics Price Competition and Innovation Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Medicare Access to Rehabilitation Services Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Stem Cell Research Enhancement Act of 2007
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To amend the Internal Revenue Code of 1986 with respect to the treatment of crops destroyed by casualty.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To ratify the authority of the Federal Trade Commission to establish a do-not-call registry.
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: PARKINSON'S ACTION NETWORK · Firm: PARKINSON'S ACTION NETWORK
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2009 · first_quarter · Q1
HR 1362, "The National MS and Parkinson's Disease Registries Act," all sections; "Department of Defense Appropriations Act, 2010," section related to the Neurotoxin Exposure Treatment Parkinson's Research (NETPR) program; HR 1, "The American Recovery and Reinvestment Act, 2009," all sections relating to the National Institutes of Health; HR 1105, "The Omnibus Appropriations Act, 2009," sections relating to the National Institutes of Health and the Food and Drug Administration; HR 873/S 487, "Stem Cell Research Enhancement Act of 2009," all sections; HR 1260/S 610, "Patent Reform Act of 2009," sections related to diagnostic and therapeutic product development; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2010," all sections related to the Food and Drug Administration.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2008 · fourth_quarter · Q4
S. 5/HR. 3, " Stem Cell Research Enhancement Act" all sections; H.R.5874, "National MS Disease Registry Act" all sections; S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2008 · third_quarter · Q3
"The Medicare Improvement for Patients and Providers Act of 2008," all sections related to Medicare Part D coverage
H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. S. 3230 "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; S. 3289 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA; H.R.2638 "Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009," all sections related to the National Institutes of Health, section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program, all sections related to FDA; H.R. 6331, S. 1693 "The Wired for Health Care Quality Act," all sections related to health information technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2008 · second_quarter · Q2
H.R. 493, "Genetic Information Nondiscrimination Act," all sections. H.R. 5819, "SBIR/STTR Reauthorization Act," Title II regarding participation of venture capital funded small businesses and all sections related to National Institutes of Health. H.R. 2642 the "Consolodated Supplemental Appropriations Act, 2008," all sections related to National Institutes of Health and the Food and Drug Administration. "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2009," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2009" all sections related to FDA;
S. 2931, the "Medicare Access to Complex Rehabilitation and Assistive Technology Act of 2008," all sections. H.R. 6331 the "Medicare Improvement for Patients and Providers Act," all sections.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2008 · first_quarter · Q1
Medicare Part D plan issues for enrolled beneficiaries with chronic diseases, including dual eligible and other full-subsidy individuals.
"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008," all sections related to the National Institutes of Health; "Department of Defense Appropriations Act, 2008," section related to the Neurotoxin Exposure Treatment Research Parkinson's (NETRP) program; "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2008" all sections related to FDA; "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2007 · year_end · YY
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2007 · mid_year · MM
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2006 · year_end · YA
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2006 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2005 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2005 · mid_year · MM
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
PARKINSON'S ACTION NETWORK via PARKINSON'S ACTION NETWORK
2004 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA. S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
HR 748/S 450, "The Medicare Access to Rehabilitation Services Act," all sections.
S 1082, "The FDA Revitalization Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act ; HR 2900, "The FDA Amendments Act," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act; H.R. 1561, "The Enhancing Drug Safety and Innovation Act of 2007," all sections related to drug development and reauthorization of the Prescription Drug User Fee Act. S 1695, "The Biologics Price Competition and Innovation Act of 2007," all sections; HR 3/S 5, "The Stem Cell Research Enhancement Act," all sections. HR 3043/S 1710, "Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2007," all sections related to the National Institutes of Health; HR 3222, "Department of Defense Appropriations Act, 2007," section related to the Neurotoxin Exposure Treatment Research Program; HR 3161/S1859 "Department of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act," all sections related to FDA.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE